Actively Recruiting
Prospective Study to Evaluate High Flow Nasal Cannula With Monitored Anesthesia Care During EBUS Bronchoscopy
Led by The Cooper Health System · Updated on 2025-09-25
198
Participants Needed
1
Research Sites
221 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Our objective is to assess whether the use of high flow nasal cannula (Vapotherm, Exeter, NH) with monitored anesthesia care (MAC) during an endobronchial ultrasound (EBUS) bronchoscopy procedure will lead to less procedure interruptions, less hypoxic episodes, shorter duration of hypoxic episodes and shorter procedural durations when compared to regular MAC using a regular nasal canula.
CONDITIONS
Official Title
Prospective Study to Evaluate High Flow Nasal Cannula With Monitored Anesthesia Care During EBUS Bronchoscopy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age over 18 years
- Patient undergoing EBUS bronchoscopy with moderate conscious sedation
You will not qualify if you...
- Previous nasal surgeries
- Oxygen saturation below 90% on room air before the procedure
- Pregnancy
- Known facial fractures or recent facial trauma
- Use of anticoagulation medication that cannot be stopped before the procedure
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Cooper University Hospital
Camden, New Jersey, United States, 08103
Actively Recruiting
Research Team
W
Wissam Abouzgheib, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here